Breast cancer (BC) is a heterogeneous malignancy that still represents the second cause of
cancer-related death among women worldwide. Due to the heterogeneity of BC, the correct …

Following the previous part of the narrative review on artificial intelligence (AI) applications
in positron emission tomography (PET) using tracers rather than 18 F-fluorodeoxyglucose …

Breast cancer (BC) is a heterogeneous disease, affecting millions of women every year.
Early diagnosis is crucial to increasing survival. The clinical workup of BC diagnosis …

Simple Summary Breast cancer is considered as the most common malignancy among
females, and its treatment takes many forms and types. Neoadjuvant chemotherapy (NACT) …

The early prediction of a patient's response to neoadjuvant chemotherapy (NAC) in breast
cancer treatment is crucial for guiding therapy decisions. We aimed to develop a novel …

The advent of hybrid Positron Emission Tomography/Computed Tomography (PET/CT) and
PET/Magnetic Resonance Imaging (MRI) scanners resulted in an increased clinical …

Background The aim of this study was to evaluate the clinical usefulness of radiomics
signature-derived 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography …

Background: 18F-FDG PET/CT imaging represents the most important functional imaging
method in oncology. European Society of Medical Oncology and the National …

Traditional imaging techniques for breast cancer (BC) diagnosis and prediction, such as X-
rays and magnetic resonance imaging (MRI), demonstrate varying sensitivity and specificity …

Breast cancer is a common but heterogeneous disease characterized by several biologic
features, including tumor grade, hormone receptor status, human epidermal growth factor …